Menu
GeneBe

10-67797189-C-T

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong

The NM_021800.3(DNAJC12):​c.524G>A​(p.Trp175Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000973 in 1,613,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000084 ( 0 hom. )

Consequence

DNAJC12
NM_021800.3 stop_gained

Scores

3
3
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:6

Conservation

PhyloP100: 2.86
Variant links:
Genes affected
DNAJC12 (HGNC:28908): (DnaJ heat shock protein family (Hsp40) member C12) This gene encodes a member of a subclass of the HSP40/DnaJ protein family. Members of this family of proteins are associated with complex assembly, protein folding, and export. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 5 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-67797189-C-T is Pathogenic according to our data. Variant chr10-67797189-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 870655.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-67797189-C-T is described in Lovd as [Pathogenic]. Variant chr10-67797189-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
DNAJC12NM_021800.3 linkuse as main transcriptc.524G>A p.Trp175Ter stop_gained 5/5 ENST00000225171.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
DNAJC12ENST00000225171.7 linkuse as main transcriptc.524G>A p.Trp175Ter stop_gained 5/51 NM_021800.3 P1Q9UKB3-1
DNAJC12ENST00000483798.6 linkuse as main transcriptc.614G>A p.Trp205Ter stop_gained 6/63

Frequencies

GnomAD3 genomes
AF:
0.000223
AC:
34
AN:
152150
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000172
AC:
43
AN:
250564
Hom.:
0
AF XY:
0.000192
AC XY:
26
AN XY:
135592
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000958
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000328
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000707
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000842
AC:
123
AN:
1461390
Hom.:
0
Cov.:
30
AF XY:
0.0000784
AC XY:
57
AN XY:
726956
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00123
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000504
Gnomad4 OTH exome
AF:
0.000182
GnomAD4 genome
AF:
0.000223
AC:
34
AN:
152268
Hom.:
0
Cov.:
33
AF XY:
0.000269
AC XY:
20
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.00150
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000103
Hom.:
0
Bravo
AF:
0.000261
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperphenylalaninemia due to DNAJC12 deficiency Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsApr 14, 2022- -
Pathogenic, no assertion criteria providedresearchCentro de Biología Molecular Severo Ochoa, Universidad Autónoma de MadridFeb 12, 2020- -
Pathogenic, criteria provided, single submitterclinical testingNew York Genome CenterJul 22, 2021- -
DNAJC12-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesJun 13, 2023The DNAJC12 c.524G>A variant is predicted to result in premature protein termination (p.Trp175*). This variant has been reported in the homozygous and compound heterozygous state in multiple individuals with hyperphenylalaninaemia (Navarrete et al 2019. PubMed ID: 30626930; Gallego D et al 2020. PubMed ID: 32333439). This variant is reported in 0.093% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/10-69556947-C-T). Nonsense variants in DNAJC12 are expected to be pathogenic. This variant is interpreted as pathogenic. -
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingAmbry GeneticsJul 30, 2021The c.524G>A (p.W175*) alteration, located in exon 5 (coding exon 5) of the DNAJC12 gene, consists of a G to A substitution at nucleotide position 524. This changes the amino acid from a tryptophan (W) to a stop codon at amino acid position 175. This alteration occurs at the 3' terminus of the DNAJC12 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 12.2% (24/198 amino acids) of the protein. However, premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). This alteration has been detected in the homozygous and compound heterozygous states in multiple individuals with hyperphenylalaninemia (HPA) (Gallego, 2020). Functional studies on fibroblasts showed reduced amounts of PAH and PAH activity affecting the PAH folding process. Steady-state tyrosine hydroxylase levels were also reduced while tryptophan hydroxylase 2 levels were not affected (Gallego, 2020). Based on the available evidence, this alteration is classified as pathogenic. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 02, 2024This sequence change creates a premature translational stop signal (p.Trp175*) in the DNAJC12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 24 amino acid(s) of the DNAJC12 protein. This variant is present in population databases (rs370032864, gnomAD 0.1%). This premature translational stop signal has been observed in individuals with hyperphenylalaninemia (PMID: 30626930, 32333439). ClinVar contains an entry for this variant (Variation ID: 870655). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects DNAJC12 function (PMID: 32333439). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.63
CADD
Pathogenic
37
DANN
Uncertain
0.99
Eigen
Pathogenic
0.81
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.87
D
MutationTaster
Benign
1.0
D
Vest4
0.24
GERP RS
5.9

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370032864; hg19: chr10-69556947; API